Conduct Temperature Mapping of Transit Vehicles in GMP Logistics
Remember: Always perform temperature mapping of vehicles used for pharmaceutical product transport — it ensures thermal stability and protects product integrity.
Why This Matters in GMP
Pharmaceutical products, especially temperature-sensitive ones (e.g., vaccines, biologics, hormones), require strict thermal control throughout their distribution lifecycle. Delivery vehicles, if not validated through temperature mapping, can develop hot or cold spots due to insulation gaps, air circulation inconsistencies, or external climate influence. Mapping ensures that all areas within the transit chamber maintain the required temperature range under real-world operating conditions.
For example, if insulin is transported in an unvalidated vehicle during summer, uneven air distribution may cause a temperature rise at the corners of the trailer — risking degradation and loss of potency. Mapping allows identification of risk zones, placement of monitoring probes, and ensures reliable performance across different ambient conditions.
Regulatory and Compliance Implications
21 CFR Part 211.150 mandates distribution procedures that ensure product quality is maintained. EU GDP and EU GMP guidelines require temperature-controlled transportation to be validated and mapped. WHO GMP and TRS 957 highlight mapping as essential for cold chain integrity and product safety during transit.
Auditors
Implementation Best Practices
Conduct thermal mapping studies under empty and loaded conditions across different seasons. Use calibrated data loggers to record temperature at multiple points (e.g., floor, ceiling, corners, door zones). Analyze data for variance and establish qualified loading patterns that maintain required ranges (e.g., 2–8°C, 15–25°C).
Develop SOPs for vehicle qualification, data logger placement, and routine re-mapping. Train logistics and QA teams on transport condition monitoring, emergency handling of excursions, and temperature data review. Link mapping records to batch release and distribution authorization processes.
Regulatory References
– 21 CFR Part 211.150 – Distribution procedures
– EU GDP Guidelines – Transport and temperature control
– WHO TRS 957, Annex 5 – Temperature-controlled transport
– USP – Good Storage and Distribution Practices